Temasek to Invest in Shanghai Pharma’s $2.2 Billion Offering

Shanghai Pharmaceuticals Holding Co., China’s second-largest drug distributor, will sell new shares to Temasek Holdings Pte and Pfizer Inc. in an offering in Hong Kong of as much as $2.2 billion of stock to fund acquisitions.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.